Table 2. Distribution of gleason score and stromal reactivity in prostatic adenocarcinoma without stromal reactivity (group-1) and with intense stromal reactivity (group-2).

Gleason score	Number of cases (%)	Group-1	Group-2
Gleason 4 (2+2)	1 (2.5%)	1 (100.0%)*	0 (0.0%)
Gleason 5 (3+2)	2 (5.0%)	2 (100.0%)*	0 (0.0%)
Gleason 6 (3+3)	19 (47.5%)	16 (84.2%)*	3 (15.8%)
Gleason 7 (3+4)	10 (25.0%)	1 (10.0%)	9 (90.0%)*
Gleason 7 (4+3)	8 (20.0%)	0 (0.0%)	8 (100.0%)*
Total	40 (100.0%)	20 (50.0%)	20 (50.0%)